Valuation: AVRA Medical Robotics, Inc.

Market Cap 83Cr 73Cr 67Cr 63Cr 117.96Cr 7.9TCr 120.35Cr 807.31Cr 312.79Cr 3.88TCr 311.85Cr 305.1Cr 13TCr P/E 2026 *
-69.2x
P/E 2027 * -69.2x
Enterprise Value 83Cr 73Cr 67Cr 63Cr 117.96Cr 7.9TCr 120.35Cr 807.31Cr 312.79Cr 3.88TCr 311.85Cr 305.1Cr 13TCr EV / Sales 2026 *
14x
EV / Sales 2027 * 11x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
Change 5-day change 1-year change 3-year change Capi.($)
-3.50%-.--% - - 5.12Cr
+3.08%+6.47%-0.25%+6.27% 4.72TCr
-0.20%+10.02%+406.32%+596.16% 3.98TCr
+4.97%+9.30%+24.77%-8.22% 3.22TCr
+2.01%+4.72%+18.37%+60.46% 3.17TCr
+0.69%+8.72%+14.80%+30.86% 2.46TCr
+0.34%+11.89% - - 1.66TCr
+3.48%+6.69%+70.41%+128.88% 1.51TCr
-0.15%+2.15%+12.64%+17.55% 1.37TCr
-0.24%+3.31%+97.92%+92.43% 1.31TCr
Average +1.02%+7.37%+80.62%+115.55% 2.6TCr
Weighted average by Cap. +1.78%+7.41%+93.97%+137.25%

Financials

2026 *2027 *
Net sales 5.94Cr 5.22Cr 4.8Cr 4.47Cr 8.44Cr 564.73Cr 8.61Cr 58Cr 22Cr 277.2Cr 22Cr 22Cr 964.74Cr 7.52Cr 6.6Cr 6.08Cr 5.66Cr 11Cr 714.95Cr 11Cr 73Cr 28Cr 350.94Cr 28Cr 28Cr 1.22TCr
Net income -1.2Cr -1.05Cr -96.98L -90.37L -1.7Cr -114.09Cr -1.74Cr -12Cr -4.52Cr -56Cr -4.51Cr -4.41Cr -194.9Cr -1.4Cr -1.23Cr -1.13Cr -1.05Cr -1.99Cr -133.1Cr -2.03Cr -14Cr -5.27Cr -65Cr -5.26Cr -5.14Cr -227.38Cr
Net Debt - -
Logo AVRA Medical Robotics, Inc.
SS Innovations International, Inc., formerly AVRA Medical Robotics, Inc, is a medical robotics company. The Company is engaged in developing a fully autonomous medical robotic system using its software, which integrates artificial intelligence (AI) and deep learning, or machine learning (DL). By using an AI and DL-enhanced software program, it is creating an intelligent robotic system that robotizes a range of medical procedures. It is developing a treatment-independent autonomous robotics system utilizing its AI-driven precision guidance system, applicable to a variety of minimally and non-invasive procedures, with a focus on skin resurfacing aesthetic procedures. Its medical robotic system is being developed to deliver skin resurfacing treatments, such as micro-needling and laser therapies. Its autonomous medical robotics system is being developed to be compatible with available surgical tools and end-effectors, enabling it to enter the micro-needling and laser solutions market.
Employees
-